Skip to main content

Entyvio 300 mg lyophilized powder for injection Images

Generic Name: vedolizumab

This medication has been identified as Entyvio 300 mg lyophilized powder for injection. It is supplied by Takeda Pharmaceutical Company Limited.

Entyvio is used in the treatment of Ulcerative Colitis; Crohn's Disease, Maintenance; Crohn's Disease and belongs to the drug class selective immunosuppressants. There is no proven risk in humans during pregnancy. Entyvio 300 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Entyvio 300 mg lyophilized powder for injection medicine

Entyvio

Generic Name
vedolizumab
Strength
300 mg lyophilized powder for injection
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceutical Company Limited
National Drug Code (NDC)
64764-0300

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.